Can the stockmarket swallow Anthropic, SpaceX and OpenAI?

SpaceX reportedly hopes to raise $75bn in a June 11 listing, with Anthropic and OpenAI each rumoured to target up to $60bn in future IPOs. Together, the three potential giga-IPOs could add as much as $4trn to the market value of listed U.S. companies within months. The article frames these deals as evidence of an oversized private-market pipeline and the public market’s capacity strain rather than as a company-specific operating update.

Analysis

The real market impact is not the headline valuation, it is the timing mismatch between private-market price discovery and public-market absorbency. If these names print anywhere near the rumored sizes, the listing calendar becomes a liquidity event for the entire growth complex: passive benchmarks will have to add them, sell-side hedging flows will crowd into a narrow set of liquid adjacencies, and secondary-market investors may de-risk preemptively in existing software, internet, and AI infrastructure names to make room. That creates a short-term relative-value opportunity: the beneficiaries are not necessarily the issuers, but the exchanges, underwriters, index providers, and anyone with direct monetization of listing activity and trading volume.

NDAQ is the cleanest expression of that second-order effect. A wave of mega-IPOs should lift equity issuance fees, trading volumes, and options activity, but the bigger earnings lever is likely durably higher market data and index-license revenue if these listings become benchmark constituents. The risk is that the market treats this as a one-time fee windfall rather than a multi-quarter volume/engagement upgrade; if broader risk appetite weakens, the IPO pipeline can still price, but aftermarket performance may collapse, which would quickly shut the door on follow-on issuance and damp the medium-term benefit.

The contrarian angle is that the market may be overestimating how much fresh capital these listings actually attract versus how much they re-label existing private wealth. If the deals are primarily a liquidity transfer from private markets to public holders, the net new buying power is smaller than the market-cap headline suggests, raising the odds of post-listing indigestion in high-duration growth names. That argues for skepticism toward chasing the first-day pop and for monitoring whether the market uses the event to de-gross from crowded AI and venture proxies rather than broaden risk.

Key Decisions for Investors

• Long NDAQ vs short IWM for 4-8 weeks: express the view that mega-IPO activity boosts exchange economics more than broad small-cap risk appetite; target 5-10% relative outperformance if issuance accelerates.
• Buy near-dated NDAQ call spreads into filing-to-pricing windows: asymmetric upside if volumes and options activity re-rate, with defined downside if the IPO calendar slips.
• Reduce exposure to crowded late-stage private/AI proxies over the next 1-3 months; use any IPO-related strength to trim names that trade on scarcity premium rather than cash flow.
• Pair short-duration high-multiple software basket vs long exchanges/market infrastructure for a 1-2 quarter horizon: the setup favors capital rotation from narrative-driven growth into fee-taking intermediaries.
• If the first offering trades weakly aftermarket, fade the entire theme by adding to short volatility in IPO-linked names; poor debuts would likely compress the next 60-90 days of issuance expectations.